Orphazyme A/S ADR

Orphazyme A/S is a late-stage biopharmaceutical company pioneering the Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases. The company's product candidate includes Niemann-Pick disease Type C, Amyotrophic Lateral Sclerosis, sporadic Inclusion Body Myositis and Gaucher disease which are in clinical stage. It operates principally in the U.S. and Switzerland. Orphazyme A/S is headquartered in Denmark.

Address Details

Address: OLE MAALOES VEJ 3

City: COPENHAGEN N

State: G7

Country: DNK

Zip Code: DK-2200